(NEW YORK) — The window for helping certain stroke patients with a potentially life-saving blood clot removal surgical treatment may be longer than previously thought, according to a study published ...

The ENRICH trial, showing improved functional outcomes with surgical clot evacuation plus medical management, has now been published in The New England Journal of Medicine. The trial results were ...

Removing a clot blocking a medium- or small-sized artery in the brain mechanically is a safe treatment for a common type of stroke; however, it did not lessen disability more than best medical ...

A major international analysis of 2,313 patients, median age 71, found that giving an IV clot-busting drug before mechanical clot removal modestly increases brain-bleeding risk compared with ...

LOS ANGELES — Using low-dose tissue plasminogen activator (tPA; alteplase) delivered by surgical catheter to remove clots of pooled blood from the brain's ventricles after intraventricular hemorrhage ...

Inari Medical has updated use instructions for its ClotTriever XL catheter after four injuries and six deaths were reported in association with the device. The ClotTriever XL is used for removing ...

Researchers at Stanford University say they have developed a more effective way to treat strokes. The new technology, called the milli-spinner thrombectomy, has been shown to have more successful ...

According to the World Health Organization, nearly 15 million people suffer a stroke every year worldwide. Ischemic strokes caused by blood clots blocking brain arteries account for about 87 percent ...

Dr. Robert Starke introduced the Complete Clot Ingestion (CCI) metric at SNIS 2024, highlighting the ALGO Smart Pump's potential in stroke thrombectomy. The ALGO Smart Pump, with its Adaptive ...

Throughout October, we are observing the first annual Emily Adkins Blood Clot Awareness Month in honor of our daughter Emily, who died Oct. 21, 2022, from an undiagnosed blood clot. Even as it marks a ...

Lumosa Therapeutics (Lumosa; 6535.TWO) and CHI Memorial have announced the initiation of a Phase 2b clinical trial for LT3001, a groundbreaking drug for treating acute stroke. This new drug combines ...